Cortechs.ai | The Strangest Feeling: Temporal Lobe Epilepsy (TLE)

The Strangest Feeling: Temporal Lobe Epilepsy (TLE)

The team at Cortechs.ai is always looking to further educate ourselves about how brain volumetric imaging is used in the assessment of neurodegenerative conditions. Recently, a practicing Clinical Neuropsychologist visited our San Diego headquarters and gave a very interesting presentation about Temporal Lobe Epilepsy (TLE), its treatments, and how volumetric MRI is involved in the diagnosis.

Seizures are common, and having a single seizure does not mean a person has epilepsy. 4% of the population will have a single seizure at some point in their lifetime. Epilepsy occurs when someone has multiple recurring and unprovoked seizures. 2.2 million people are living with epilepsy in the U.S., and about 150,000 are newly diagnosed per year.

Cortechs.ai | The Strangest Feeling: Temporal Lobe Epilepsy (TLE)
image credit: Epilepsy Foundation

Of the various forms of epilepsy, Temporal Lobe Epilepsy (TLE) is the most common (65% of all cases). For 20-30% of people living with TLE, anti-seizure medications do not work. Physicians and researchers haven’t yet pinpointed what causes TLE. They do know, however, that certain aspects might lead to epilepsy in the future, such as a history of febrile convulsions under the age of 5 and a family history of epilepsy. Early intervention can improve the quality of life for people with TLE. Surgery can be an effective treatment option, especially for those where the source of the seizures is clear and where the medicines don’t control the seizures.

TLE is localized in the temporal lobe of one side of the brain with the hippocampus being the most common structure affected. Diagnosis of TLE is made using an electroencephalogram (EEG), which detects electrical activity in the brain using electrodes attached to the scalp. A MRI scan of the brain is typically performed, to give physicians better visualization on the brain and help determine which structure on which side of the brain may have structural damage, and thus could be the source of the seizures.

NeuroQuant® is a leading medical device software that is used in post-processing of the MRI scan. It maps the sub-cortical brain structures and provides their volumetric imaging. NeuroQuant uses the images from the MRI scan to measure the volume of certain brain structures and the asymmetry between them, in this case the left and right hippocampi, providing important information in the assessment of temporal lobe epilepsy. For TLE, the NeuroQuant Hippocampal Volume Asymmetry Report can be used to help assess which side of the hippocampus may have damage and thus could be causing the seizures, especially in subtle instances.

 

  1. Farid, Nikdokht et al. (2012). Temporal Lobe Epilepsy: Quantitative MR Volumetry in Detection of Hippocampal Atrophy. Radiology: 264(2).
  2. http://www.epilepsy.com/learn/types-epilepsy-syndromes/temporal-lobe-epilepsy
  3. http://www.radiologyassistant.nl/en/p4f53597deae16/role-of-mri-in-epilepsy.html

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.
Scroll to Top